Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This drug may be administered as 1 tablet once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly.
Assessment of renal function is recommended before and periodically during treatment with this drug.
- If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater
No dosage adjustment based on renal function is required.
- Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medication is used along with dietary and exercise therapy to help patients with type 2 diabetes achieve better blood sugar control. The two ingredients, sitagliptin and pioglitazone, work together to enhance blood sugar control and assist patients in managing their blood sugar levels. Therefore, this medication is effectively used in the treatment of type 2 diabetes.
Dosage and Administration
Adult dosage
This drug may be administered as 1 tablet once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly.
Assessment of renal function is recommended before and periodically during treatment with this drug.
- If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater
No dosage adjustment based on renal function is required.
- Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.
Precautions
This medication contains sitagliptin and pioglitazone, each with specific precautions.
First, sitagliptin can occasionally cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, immediate discontinuation of the medication and consultation with a doctor is necessary.
Additionally, sitagliptin may cause pancreatitis, which is inflammation of the pancreas; thus, if symptoms like abdominal pain, vomiting, or loss of appetite arise, inform medical personnel immediately.
Pioglitazone may worsen heart failure, so patients with heart failure or a history of heart failure should not take this medication.
During treatment with this medication, patients should regularly monitor for signs of heart failure such as weight gain, swelling, or difficulty breathing, and report any symptoms to their physician promptly.
Moreover, pioglitazone can increase the risk of bladder cancer, therefore, patients with current active bladder cancer or a past history of bladder cancer should not use this medication.
In cases of liver dysfunction or severe renal impairment, caution is advised in using this medication, and regular assessments of liver and kidney function should be performed.
Women who are pregnant or may become pregnant should avoid using this medication, and premenopausal women should take precautions against pregnancy.
This medication carries a risk of hypoglycemia; therefore, patients, especially those taking it with insulin or sulfonylureas, should frequently check blood sugar levels and be aware of hypoglycemic symptoms.
Additionally, if sudden joint pain or skin blisters appear during treatment, it is crucial to consult a doctor immediately.
Lastly, this medication may interact with various other medications; thus, patients taking other medications should inform their healthcare provider, and dosage adjustments may be necessary depending on the medications being used.
Side effects
Anaphylaxis
angioedema
Stevens-Johnson syndrome
acute pancreatitis
congestive heart failure
fluid retention
edema
hypoglycemia
upper respiratory tract infection
nasopharyngitis
Show 57 moreCollapse
headache
diarrhea
abdominal pain
nausea
constipation
rash
urticaria
cutaneous vasculitis
severe and disabling arthralgia
blistering pemphigoid
myalgia
limb pain
back pain
interstitial lung disease
pruritus
thrombocytopenia
rhabdomyolysis
dyspepsia
dizziness
increased blood triglycerides
elevated low-density lipoprotein
hyperglycemia
pneumonia
diabetic complications
metabolic acidosis
falls
cardiac arrest
elevated liver enzyme levels
acute renal failure
vomiting
severe hypoglycemia
increased serum creatinine
worsening of liver disease
urticaria
eczema
arthralgia
knee abnormalities
loss of arm strength
proteinuria
anxiety
insomnia
drowsiness
simple herpes
blurred vision
hypertension
heart failure
orthostatic hypotension
palpitations
stroke
sexual dysfunction
myocardial infarction
abdominal pain
heart failure
decreased vision
liver failure
macular edema
fracture
Not everyone experiences these, and they can vary from person to person.
Storage
Store this medication in a tightly sealed container to protect it from air, and keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and prevent degradation.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.